| Literature DB >> 26247924 |
Giuliano Malloci1, Attilio Vittorio Vargiu2, Giovanni Serra3, Andrea Bosin4, Paolo Ruggerone5, Matteo Ceccarelli6.
Abstract
We present an on-line database of all-atom force-field parameters and molecular properties of compounds with antimicrobial activity (mostly antibiotics and some beta-lactamase inhibitors). For each compound, we provide the General Amber Force Field parameters for the major species at physiological pH, together with an analysis of properties of interest as extracted from µs-long molecular dynamics simulations in explicit water solution. The properties include number and population of structural clusters, molecular flexibility, hydrophobic and hydrophilic molecular surfaces, the statistics of intraand inter-molecular H-bonds, as well as structural and dynamical properties of solvent molecules within first and second solvation shells. In addition, the database contains several key molecular parameters, such as energy of the frontier molecular orbitals, vibrational properties, rotational constants, atomic partial charges and electric dipole moment, computed by Density Functional Theory. The present database (to our knowledge the first extensive one including dynamical properties) is part of a wider project aiming to build-up a database containing structural, physico-chemical and dynamical properties of medicinal compounds using different force-field parameters with increasing level of complexity and reliability. The database is freely accessible at http://www.dsf.unica.it/translocation/db/.Entities:
Keywords: all-atom force fields; antimicrobial compounds; molecular databases; molecular dynamics simulations
Mesh:
Substances:
Year: 2015 PMID: 26247924 PMCID: PMC6332394 DOI: 10.3390/molecules200813997
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
List of antimicrobial compounds included in the current version of the database.
| Compound | Molecular | Number | Molecular | Physiological | |
|---|---|---|---|---|---|
| Formula | of Atoms | Weight | Charge | ||
| Carbapenems | |||||
| Imipenem | C12H17N3O4S | 37 | 299.3461 | 0 | |
| Panipenem | C15H21N3O4S | 44 | 339.4099 | 0 | |
| Biapenem | C15H18N4O4S | 42 | 350.3928 | 0 | |
| Meropenem | C17H25N3O5S | 51 | 383.4625 | 0 | |
| Meropenem 2 | C17H25N3O5S | 51 | 383.4625 | 0 | |
| Doripenem | C15H24N4O6S | 51 | 420.5043 | 0 | |
| Ertapenem | C22H24N3O7S | 57 | 474.5069 | –1 | |
| Cephalosporins | |||||
| Cefoxitin | C16H16N3O7S2 | 44 | 426.4441 | –1 | |
| Cefotaxime | C16H16N5O7S2 | 46 | 454.4575 | –1 | |
| Cefepime | C19H24N6O5S2 | 56 | 480.5611 | 0 | |
| Cefpirome | C22H22N6O5S2 | 57 | 515.5773 | 0 | |
| Ceftobiprole | C20H22N8O6S2 | 58 | 534.5687 | 0 | |
| Ceftazidime | C22H21N6O7S2 | 58 | 545.5681 | –1 | |
| Monocyclic beta-lactams | |||||
| Aztreonam | C13H15N5O8S2 | 43 | 433.41690 | –2 | |
| Tigemonam | C12H13N5O9S2 | 41 | 435.3897 | –2 | |
| Carumonam | C12H12N6O10S2 | 42 | 464.3879 | –2 | |
| BAL19764 | C14H13N6O9S2 | 44 | 473.4178 | –1 | |
| Nocardicin | C23H22N4O9 | 58 | 498.4422 | –2 | |
| BAL300072 | C16H17N6O10S2 | 51 | 517.47038 | –1 | |
| Oxazolidinones | |||||
| Linezolid | C16H20FN3O4 | 44 | 337.3461 | 0 | |
| Sutezolid | C16H20FN3O3S | 44 | 353.41170 | 0 | |
| Penicillines | |||||
| Aminipenicillanic acid | C8H11N2O3S | 25 | 215.2495 | –1 | |
| Benzylpenicillin | C16H17N2O4S | 40 | 333.3822 | –1 | |
| Ampicillin | C16H19N3O4S | 43 | 349.4048 | 0 | |
| Carbenicillin | C17H16N2O6S | 42 | 376.3837 | –2 | |
| Ticarcillin | C15H14N2O6S2 | 39 | 382.4115 | –2 | |
| Oxacillin | C19H18N3O5S | 46 | 400.4283 | –1 | |
| Piperacillin | C23H26N5O7S | 62 | 516.5468 | –1 | |
| Quinolones | |||||
| Nalidixic acid | C12H11N2O3 | 28 | 231.2273 | –1 | |
| Norfloxacin | C16H18FN3O3 | 41 | 319.3308 | 0 | |
| Ciprofloxacin | C17H18FN3N3O3 | 42 | 331.3415 | 0 | |
| Enrofloxacin | C19H21FN3N3O3 | 47 | 358.3867 | –1 | |
| Levofloxacin | C18H19FN3N3O4 | 45 | 360.3596 | –1 | |
| Fleroxacin | C17H17F3N3O3 | 43 | 368.3304 | –1 | |
| Tetracyclines | |||||
| Minocycline | C23H27N3O7 | 60 | 457.4764 | 0 | |
| Tigecycline | C29H40N5O8 | 82 | 586.6566 | 1 | |
| Beta-lactamase inhibitors | |||||
| Clavulanic acid | C8H8NO5 | 22 | 198.1528 | –1 | |
| Sulbactam | C8H10NO5S | 25 | 232.2337 | –1 | |
| Avibactam | C7H10N3O6S | 27 | 264.2358 | –1 | |
| Tazobactam | C10H11N4O5S | 31 | 299.2831 | –1 | |
Figure 1Computational protocol adopted (See Section 2 for a description).
Figure 2Snapshots of the main page of the database (A); an individual page (B); and the General Amber Force Field parameters files downloadable for each compound (C).
Figure 3Snapshots of the general properties available for each compound (A); the molecular net charge dependence on pH computed with MarvinSketch [30] (B); and the polar/non-polar (red-white-blue color scale) molecular surfaces evaluated with the PLATINUM server [52] (C).
Figure 4Snapshots of the list of molecular properties exctracted from QM calculations (A); the electronic (B); and vibrational spectra (C); and the visual representation of the electric dipole moment (D).
Figure 5Snapshots of the some of the molecular properties exctracted from MD trajectories (A); as an example we report first and second water shells and statistics of solute-solvent H-bonds (B), and the dynamical behaviour of the relative shape anisotropy (C).
Comparison between minimal projection areas taken from Chemicalize [98] and the average values and range of variability extracted from MD runs for selected compounds.
| Compound | Minimal Projection Area (Å | ||
|---|---|---|---|
| Chemicalize | Mean ± Stdev | Min, Max (Delta) | |
| Carbapenems | |||
| Imipenem | n.a. | 44.7 ± 3.2 | 35.4, 56.6 (21.2) |
| Ertapenem | 72.6 | 57.4 ± 6.3 | 43.3, 82.5 (39.2) |
| Cephalosporins | |||
| Cefoxitin | 59.8 | 57.8 ± 5.2 | 41.9, 70.1 (28.2) |
| Ceftazidime | 66.0 | 68.3 ± 5.7 | 52.8, 88.1 (35.3) |
| Monocyclic beta-lactams | |||
| Aztreonam | 59.6 | 58.4 ± 2.7 | 48.3, 69.3 (21.0) |
| BAL30072 | n.a. | 64.7 ± 4.7 | 50.2, 81.4 (31.2) |
| Oxazolidinones | |||
| Linezolid | 47.6 | 43.4 ± 4.0 | 32.5, 53.5 (21.0) |
| Sutezolid | n.a. | 44.0 ± 3.9 | 32.6, 56.8 (24.2) |
| Penicillines | |||
| Aminopenicillanic acid | 39.9 | 38.1 ± 0.7 | 35.0, 41.5 (6.5) |
| Piperacillin | 86.6 | 77.5 ± 3.6 | 56.1, 90.0 (33.9) |
| Quinolones | |||
| Nalidixic acid | 34.3 | 36.5 ± 1.4 | 32.6, 42.7 (10.1) |
| Fleroxacin | 46.6 | 46.1 ± 1.9 | 39.8, 55.5 (15.7) |
| Tetracyclines | |||
| Minocycline | 66.2 | 67.5 ± 1.4 | 61.4, 72.9 (11.5) |
| Tigecycline | 76.2 | 76.6 ± 3.5 | 65.5, 86.7 (21.2) |
| Beta-lactamase inhibitors | |||
| Clavulanic acid | 38.6 | 37.5 ± 1.1 | 32.1, 40.4 (8.3) |
| Tazobactam | 47.0 | 44.2 ± 3.0 | 39.3, 52.5 (13.2) |
Root-mean-square displacement between the B3LYP/6-31G optimized geometry and the minimum-energy structure obtained with the GAFF parameters of the database.
| Class | Compound | RMSD (Å) |
|---|---|---|
| Carbapenems | Imipenem | 1.59 |
| Panipenem | 1.70 | |
| Biapenem | 1.69 | |
| Meropenem | 1.66 | |
| Meropenem-2 | 1.65 | |
| Doripenem | 1.66 | |
| Ertapenem | 1.71 | |
| Cephalosporins | Cefoxitin | 1.63 |
| Cefotaxime | 1.63 | |
| Cefepime | 1.62 | |
| Ceftobiprole | 1.64 | |
| Ceftazidime | 1.60 | |
| Monocyclic beta-lactams | Aztreonam | 1.60 |
| Tigemonam | 1.69 | |
| Carumonam | 1.64 | |
| BAL19764 | 1.65 | |
| Nocardicin | 1.66 | |
| BAL30072 | 1.76 | |
| Oxazolidinones | Linezolid | 1.68 |
| Sutezolid | 1.67 | |
| Penicillines | Aminopenicillanic Acid | 1.73 |
| Benzylpenicillin | 1.64 | |
| Ampicillin | 1.65 | |
| Carbenicillin | 1.68 | |
| Ticarcillin | 1.68 | |
| Oxacillin | 1.64 | |
| Piperacillin | 1.74 | |
| Quinolones | Nalidixic Acid | 1.62 |
| Norfloxacin | 1.58 | |
| Ciprofloxacin | 1.58 | |
| Enrofloxacin | 1.58 | |
| Levofloxacin | 1.56 | |
| Fleroxacin | 1.59 | |
| Tetracyclines | Minocycline | 1.62 |
| Tigecycline | 1.65 | |
| Beta-lactamase inhibitors | Clavulanic Acid | 1.66 |
| Sulbactam | 1.63 | |
| Avibactam | 1.62 | |
| Tazobactam | 1.66 |